Altogether, distant metastatic disease occurred in eight of 64 (12.5%) and 2 of 155 (1.3%) patients with tumors carrying and lacking TERT promoter mutations, respectively (P = 0.001, X 2 test). This evidence concerns the gene TERT and metastatic neoplasm.